Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872833 · ClinicalTrials.gov registry record
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 32
- Enrollment target
NCT00872833 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 32 participants.
The verdict
NCT00872833 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00872833
The ClinicalTrials.gov registry entry for NCT00872833 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00872833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00872833 about?
NCT00872833 is a clinical study titled "Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions". Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study...
What is the current status of trial NCT00872833?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2009-07. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00872833?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.